Showing 1 - 10 results of 10 for search 'Richard R. Neubig', query time: 0.04s Refine Results
  1. 1
    COVID-19—A Theory of Autoimmunity Against ACE-2 Explained

    COVID-19—A Theory of Autoimmunity Against ACE-2 Explained by Philip McMillan, Thomas Dexhiemer, Richard R. Neubig, Richard R. Neubig, Bruce D. Uhal

    Published 2021-03-01
    Get full text
    Article
  2. 2
    Role of Rho/MRTF in Aggressive Vemurafenib-Resistant Murine Melanomas and Immune Checkpoint Upregulation

    Role of Rho/MRTF in Aggressive Vemurafenib-Resistant Murine Melanomas and Immune Checkpoint Upregulation by Bardees M. Foda, Richard R. Neubig

    Published 2023-09-01
    Get full text
    Article
  3. 3
    A mechanistic review on GNAO1-associated movement disorder

    A mechanistic review on GNAO1-associated movement disorder by Huijie Feng, Suad Khalil, Richard R. Neubig, Christos Sidiropoulos

    Published 2018-08-01
    Get full text
    Article
  4. 4
    Prevention of bleomycin‐induced lung fibrosis via inhibition of the MRTF/SRF transcription pathway

    Prevention of bleomycin‐induced lung fibrosis via inhibition of the MRTF/SRF transcription pathway by Kendell M. Pawelec, Megan Varnum, Jack R. Harkema, Bruce Auerbach, Scott D. Larsen, Richard R. Neubig

    Published 2022-12-01
    Get full text
    Article
  5. 5
    Retraction: Mouse models of GNAO1-associated movement disorder: Allele- and sex-specific differences in phenotypes.

    Retraction: Mouse models of GNAO1-associated movement disorder: Allele- and sex-specific differences in phenotypes. by Huijie Feng, Casandra L Larrivee, Elena Y Demireva, Huirong Xie, Jeff R Leipprandt, Richard R Neubig

    Published 2021-01-01
    Get full text
    Article
  6. 6
    Design and synthesis of tag-free photoprobes for the identification of the molecular target for CCG-1423, a novel inhibitor of the Rho/MKL1/SRF signaling pathway

    Design and synthesis of tag-free photoprobes for the identification of the molecular target for CCG-1423, a novel inhibitor of the Rho/MKL1/SRF signaling pathway by Jessica L. Bell, Andrew J. Haak, Susan M. Wade, Yihan Sun, Richard R. Neubig, Scott D. Larsen

    Published 2013-05-01
    Get full text
    Article
  7. 7
    Inhibition of the Myocardin-Related Transcription Factor Pathway Increases Efficacy of Trametinib in <i>NRAS</i>-Mutant Melanoma Cell Lines

    Inhibition of the Myocardin-Related Transcription Factor Pathway Increases Efficacy of Trametinib in <i>NRAS</i>-Mutant Melanoma Cell Lines by Kathryn M. Appleton, Charuta C. Palsuledesai, Sean A. Misek, Maja Blake, Joseph Zagorski, Kathleen A. Gallo, Thomas S. Dexheimer, Richard R. Neubig

    Published 2021-04-01
    Get full text
    Article
  8. 8
    Phase-locked signals elucidate circuit architecture of an oscillatory pathway.

    Phase-locked signals elucidate circuit architecture of an oscillatory pathway. by Andreja Jovic, Bryan Howell, Michelle Cote, Susan M Wade, Khamir Mehta, Atsushi Miyawaki, Richard R Neubig, Jennifer J Linderman, Shuichi Takayama

    Published 2010-12-01
    Get full text
    Article
  9. 9
    In vitro and in vivo delivery of a sustained release nanocarrier-based formulation of an MRTF/SRF inhibitor in conjunctival fibrosis

    In vitro and in vivo delivery of a sustained release nanocarrier-based formulation of an MRTF/SRF inhibitor in conjunctival fibrosis by Aristides D. Tagalakis, Shivam Madaan, Scott D. Larsen, Richard R. Neubig, Peng T. Khaw, Ian Rodrigues, Saurabh Goyal, Kin Sheng Lim, Cynthia Yu-Wai-Man

    Published 2018-11-01
    Get full text
    Article
  10. 10
    Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis

    Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis by Cynthia Yu-Wai-Man, Bradley Spencer-Dene, Richard M. H. Lee, Kim Hutchings, Erika M. Lisabeth, Richard Treisman, Maryse Bailly, Scott D. Larsen, Richard R. Neubig, Peng T. Khaw

    Published 2017-03-01
    Get full text
    Article

Search Tools: